1. Home
  2. NMRA vs CIX Comparison

NMRA vs CIX Comparison

Compare NMRA & CIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • CIX
  • Stock Information
  • Founded
  • NMRA 2019
  • CIX 1993
  • Country
  • NMRA United States
  • CIX United States
  • Employees
  • NMRA N/A
  • CIX N/A
  • Industry
  • NMRA
  • CIX Industrial Machinery/Components
  • Sector
  • NMRA
  • CIX Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • CIX Nasdaq
  • Market Cap
  • NMRA 287.6M
  • CIX 275.3M
  • IPO Year
  • NMRA 2023
  • CIX 1998
  • Fundamental
  • Price
  • NMRA $1.20
  • CIX $22.60
  • Analyst Decision
  • NMRA Buy
  • CIX
  • Analyst Count
  • NMRA 8
  • CIX 0
  • Target Price
  • NMRA $10.14
  • CIX N/A
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • CIX 8.9K
  • Earning Date
  • NMRA 03-03-2025
  • CIX 03-05-2025
  • Dividend Yield
  • NMRA N/A
  • CIX 5.28%
  • EPS Growth
  • NMRA N/A
  • CIX N/A
  • EPS
  • NMRA N/A
  • CIX 1.35
  • Revenue
  • NMRA N/A
  • CIX $145,941,000.00
  • Revenue This Year
  • NMRA N/A
  • CIX N/A
  • Revenue Next Year
  • NMRA N/A
  • CIX N/A
  • P/E Ratio
  • NMRA N/A
  • CIX $16.60
  • Revenue Growth
  • NMRA N/A
  • CIX N/A
  • 52 Week Low
  • NMRA $1.13
  • CIX $20.60
  • 52 Week High
  • NMRA $17.19
  • CIX $39.91
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 28.26
  • CIX 45.66
  • Support Level
  • NMRA $1.13
  • CIX $21.39
  • Resistance Level
  • NMRA $1.48
  • CIX $23.07
  • Average True Range (ATR)
  • NMRA 0.13
  • CIX 1.08
  • MACD
  • NMRA 0.06
  • CIX 0.07
  • Stochastic Oscillator
  • NMRA 18.04
  • CIX 51.30

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

Share on Social Networks: